Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 12/20 | 0.44 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.43 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.43 |
| ▸ | SCN9A | Q15858 | 5/20 | 0.40 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL3069686 | 0.90 | STAT3 (0.46) | STAT3PIK3CAPRKAA2SCN9AMAPT | |
| SCHEMBL10182042 | 0.90 | STAT3 (0.45) | STAT3PIK3CAPRKAA2SCN9AMAPT | |
| Oxalic Acid SCHEMBL3051563 | 0.90 | STAT3 (0.47) | STAT3PIK3CAPRKAA2MAPTHTT | |
| SCHEMBL10181380 | 0.88 | STAT3 (0.48) | STAT3PIK3CAPRKAA2SCN9AMAPT | |
| SCHEMBL3067943 | 0.85 | MAPT (0.53) | STAT3PIK3CAPRKAA2SCN9AMAPT | |
| SCHEMBL10181050 | 0.85 | STAT3 (0.59) | STAT3PIK3CAPRKAA2 | |
| SCHEMBL3050846 | 0.85 | SCN9A (0.47) | STAT3PIK3CAPRKAA2SCN9AMAPT | |
| Maleic Acid SCHEMBL3056841 | 0.83 | STAT3 (0.56) | STAT3PIK3CAPRKAA2 | |
| Fumaric Acid SCHEMBL3056843 | 0.83 | STAT3 (0.56) | STAT3PIK3CAPRKAA2 | |
| Oxalic Acid SCHEMBL3067548 | 0.82 | STAT3 (0.54) | STAT3PIK3CAPRKAA2SCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8551999-B2 | Heterocyclic compound and pharmaceutical composition thereof | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-10-08 | — | — | US | disclosed |
| EP-2207773-B1 | HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF | OTSUKA PHARMA CO LTD (JP) | 2012-07-11 | — | — | EP | disclosed |
| US-20100261720-A1 | HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2010-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261720-A1 | HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF | COL1A1, COL2A1, COL14A1 | STAT3 1499/4885PIK3CA 3582/4885PRKAA2 4297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.